Abstract:BackgroundInterleukin-24(IL-24), also referred to as melanoma differentiation-associated gene-7(mda-7), is a unique member of the IL-10 gene family, which displays nearly ubiquitous cancer-specific toxicity. The most notable feature of IL-24 is selectively induced growth suppression and apoptosis in various cancer cells, with no harmful effects toward normal cells. Autophagy is a self-protective mechanism in many kinds of tumor cells that respond to anticancer treatment. It is reported that autophagy inhibition could enhance the effects of many kinds of anticancer treatments, including gene therapy. However, whether IL-24 is effective to treat oral squamous cell carcinomas (OSCC) and if autophagy inhibition could improve the anticancer effect of IL-24 towards OSCC is has not been detected.MethodsMTT assays were carried out to determine the cell proliferation; Transfection was used to gene transfer; Western Blot was performed to detect the protein level of LC3II, P62, Beclin 1, Cleaved caspase-3, β-Tubulin and β-actin; Apoptosis rates and cell cycle alteration were analyzed using flow cytometry; Autophagy induction was confirmed by MDC staining, GFP-LC3 staining and transmission electron microscopy. Amount of IL-24 in the culture medium was quantified by ELISA. Apoptosis in vivo was analyzed by TUNEL assay. HE staining was used to observe the morphology of the samples.ResultsIn the present study, we proved that IL-24 have a novel anticancer effect towards KB cells and that autophagy inhibition could improve the anticancer effect of IL-24. IL-24 treated cells showed autophagy characteristics and autophagy inhibition by 3-methyladenine (3-MA) significantly enhanced IL-24-induced apoptosis. Similar results were obtained in the KB cells xenograft tumor model.ConclusionsThese results suggest that the combination of autophagy inhibitors and IL-24 based on the AdLTR2EF1α-mediated gene transfer could be a promising way to cure OSCC.

The Mechanisms of Antitumor Mediated by IL-24

The Mechanism of Tumor Cells Apoptosis Selectively Induced by IL-24

The Progress of Interleukin-24 Study

Interleukin (IL)-24 Transforms the Tumor Microenvironment and Induces Anticancer Immunity in a Murine Model of Colon Cancer.

[Mechanisms Responsible for Antitumor Activity of Melanoma Differentiation-Associated Gene -7/Interleukin-24].

[Research Advance of Interleukin 24].

Phosphorylation of interleukin (IL)-24 is required for mediating its anti-cancer activity

[Interleukin 24 Inhibits Growth and Induces Apoptosis of Osteosarcoma Cells MG-63 in Vitro and in Vivo].

[The Expression of Recombinant Protein of Human Interleukin-24 and Its Anti-Tumor Mechanism].

IL-24 Gene Transfer Sensitizes Melanoma Cells to Erlotinib Through Modulation of the Apaf-1 and Akt Signaling Pathways.

Hypalgesia Effect of IL-24, a Quite New Mechanism for IL-24 Application in Cancer Treatment.

Inhibition of autophagy by 3-MA enhances IL-24-induced apoptosis in human oral squamous cell carcinoma cells

Antitumor Activities of Interleukin-12 in Melanoma

722. Antitumor Effect of IL-24 Mediated by Tumor Targeting Vector ZD55 is Much Better Than That Mediated by Replication Deficient Adenovirus

Study on Anti-tumor Mechanisms of Recombinant Human Interleukin 24 Protein

Interleukin 24 Inhibits Growth and Induces Apoptosis of Human Large Cell Lung Cancer Cell Line Nci-H460 in Vitro

Insights into the Mechanisms of Action of MDA-7/IL-24: A Ubiquitous Cancer-Suppressing Protein

The clinical significance of Interleukin 24 and its potential molecular mechanism in laryngeal squamous cell carcinoma.

Recombinant Human Il-24 Suppresses Lung Carcinoma Cell Growth Via Induction Of Cell Apoptosis And Inhibition Of Tumor Angiogenesis

Interleukin-24 and lung cancer

The In Vitro And In Vivo Antitumor Activity Of Adenovirus-Mediated Interleukin-24 Expression For Laryngocarcinoma